Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Journal of Medical Microbiology|May 3, 2018
Contribution of efflux to colistin heteroresistance in a multidrug resistant Acinetobacter baumannii clinical isolateDiana Machado, Jéssica Antunes, Ana Simões, et al.
Frontiers in Microbiology|September 26, 2019
Experimental Evidence for Limited in vivo Virulence of Mycobacterium africanumBaltazar Cá, Kaori L Fonseca, Jeremy Sousa, et al.
Frontiers in Pharmacology|May 23, 2022
In vitro Evaluation of Isoniazid Derivatives as Potential Agents Against Drug-Resistant TuberculosisJoaquim Trigo Marquês, Catarina Frazão De Faria, Marina Reis, et al.
Carbohydrate Polymers|June 5, 2016
Thermal and magnetic properties of chitosan-iron oxide nanoparticlesPaula I P Soares, Diana Machado, César Laia, et al.
European Journal of Medicinal Chemistry|October 2, 2017
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium aviumRolando Cannalire, Diana Machado, Tommaso Felicetti, et al.
Molecular Therapy Oncolytics|February 6, 2019
Enhanced Delivery of Oncolytic Adenovirus by Neural Stem Cells for Treatment of Metastatic Ovarian CancerRachael Mooney, Asma Abdul Majid, Jennifer Batalla-Covello, et al.
In Vivo (Athens, Greece)|August 31, 2013
The in vitro activity of products formed from exposure of chlorpromazine to a 266 nm laser beam against species of mycobacteria of human interestAna Maria Armada, Tatiana Alexandru, Diana Machado, et al.
Scientific Reports|February 15, 2020
Using genomics to understand the origin and dispersion of multidrug and extensively drug resistant tuberculosis in PortugalJoão Perdigão, Pedro Gomes, Anabela Miranda, et al.
Genome Medicine|December 23, 2016
The variability and reproducibility of whole genome sequencing technology for detecting resistance to anti-tuberculous drugsJody Phelan, Denise M O'Sullivan, Diana Machado, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 28, 2021
Designing new antitubercular isoniazid derivatives with improved reactivity and membrane trafficking abilitiesCatarina Frazão de Faria, Tânia Moreira, Pedro Lopes, et al.
Pageof 8